Japan's generics drug market size 2008-2017
Value of the domestic generics drug market in Japan from 2008 to 2017 (in billion Japanese yen)
The statistic depicts the value of the domestic generics drug market in Japan between 2008 and 2017. In 2017, the Japanese generics drug market was valued at approximately 1.6 trillion Japanese yen, almost three times as large as in 2008.
Value of the domestic generics drug market in Japan from 2008 to 2017 (in billion Japanese yen)
Source
More information
Statistics on "Pharmaceutical trends in Europe"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Japan's prescription drug market size 2008-2017
- Japan's drug market sales share of generics 2008-2017
- Sawai Pharmaceutical net sales FY 2006-2016
- Nichi-Iko's drug sales distribution in Japan FY 2017, by category
- Sawai Pharmaceutical patent numbers FY 2012-2016
- Nichi-Iko's sales share of generics in Japan FY 2012-2017
- Sawai Pharmaceutical's female manager share FY 2013-2016
- Nichi-Iko's drug sales share in Japan FY 2018, by institution
- Nichi-Iko's total assets FY 2012-2018
- Sawai Pharmaceutical's employee numbers FY 2013-2016
- Nichi-Iko's coverage medical institutions Japan FY 2018, by type
- Nichi-Iko's R&D expenditure FY 2012-2018
- Sawai Pharmaceutical's total assets FY 2006-2016
- Nichi-Iko's market share generics in Japan FY 2008-2021
- Nichi-Iko's gross profit FY 2012-2018
- Sawai Pharmaceutical's net income FY 2006-2016
- Nichi-Iko's net income FY 2012-2018
- Sawai Pharmaceutical's R&D expenditure FY 2006-2016
- Major drug manufacturers Japan FY 2016, by wholesalers' sales share
- Nichi-Iko's domestic sales revenue generics FY 2012-2017
Statistics on "Pharmaceutical trends in Europe"
Related topics
About Statista
